Although most RCC organoids displayed a similar and concordant sensitivity pattern to everolimus, temsirolimus and AZD8055 (Figure 6C), remarkable differences existed in the reactions to these mTOR inhibitors by different RCC organoids. This evidence concerns the gene MTOR and renal cell carcinoma.